Patent · US Active

Immunomodulatory and anti-tumour peptides

US8283324B2 · kind B2 · utility

1Cited by

2References

18Claims

0Family size

Assignee

CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA · CU

Inventors

Maribel Guerra Vallespi · Boyeros, CU
Isis del Carmen Torréns Madrazo · Boyeros, CU
Osvaldo Reyes Acosta · Havana, CU
Hilda Elisa Garay Pérez · Boyeros, CU
Gerardo Enrique Guillen Nieto · Boyeros, CU
Boris Ernesto Acevedo Castro · Boyeros, CU
Raimundo Ubieta Gómez · Boyeros, CU

Key dates

Filing date	Feb 23, 2007
Grant date	Oct 9, 2012
Priority date	—
Expiry date	Feb 23, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to the development of peptides derived from the sequence HYRIKPTFRRLKWKYKGKFW (SEQ ID NO.: 13), showing amino acid substitutions, these peptides unable to bind to the lipopolysaccharides and bearing anti-tumoral and immunomodulatory capacities. These peptides alone or in combination are useful to treat cancer, and also in synergy with conventional therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.